Clinical Trial Update: Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the sensitivity and specificity of the QuantiFERON-TB Gold interferon-gamma release assay in patients with psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Tuberculosis

Drugs mentioned

• QuantiFERON-TB Gold (Interferon-gamma release assay (IGRA) for latent TB)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Tuberculosis, Psoriasis | Phase 4 | Status: UNKNOWN